Mineralys Drug Lowers Blood Pressure but Misses Sleep Apnea Goal
RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) reported additional clinical evidence that its experimental hypertension drug lorundrostat can lower blood pressure in patients whose condition remains uncontrolled despite multiple …
Mineralys Drug Lowers Blood Pressure but Misses Sleep Apnea Goal Read More